Page last updated: 2024-09-05

firocoxib and Animal Mammary Carcinoma

firocoxib has been researched along with Animal Mammary Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arenas, C; Granados-Soler, JL; Peña, L; Pérez-Alenza, MD	1

Other Studies

1 other study(ies) available for firocoxib and Animal Mammary Carcinoma

Article	Year
Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study. The Veterinary record, 2016, Jul-30, Volume: 179, Issue:5 Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Case-Control Studies; Chemotherapy, Adjuvant; Cyclooxygenase 2 Inhibitors; Dog Diseases; Dogs; Female; Mammary Neoplasms, Animal; Mitoxantrone; Prospective Studies; Sulfones; Treatment Outcome	2016

Article

Year

Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study.

The Veterinary record, 2016, Jul-30, Volume: 179, Issue:5

Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Case-Control Studies; Chemotherapy, Adjuvant; Cyclooxygenase 2 Inhibitors; Dog Diseases; Dogs; Female; Mammary Neoplasms, Animal; Mitoxantrone; Prospective Studies; Sulfones; Treatment Outcome

2016